Editas Medicine Inc (EDIT) returns
Editas Medicine returns over 10 years
$1,000 invested in Editas Medicine ten years ago was worth $203.82 at the close on October 30, 2026, with dividends reinvested: an average return of -14.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +3.9% | — | $1,039 | -0.9% |
| 3 months | -0.7% | — | $992.57 | +2.1% |
| Year to date | +30.2% | — | $1,302 | +11.7% |
| 1 year | -11.3% | — | $887.04 | +12.4% |
| 3 years | -57.8% | -25.0% | $421.80 | +88.5% |
| 5 years | -92.7% | -40.8% | $72.71 | +76.0% |
| 10 years | -79.6% | -14.7% | $203.82 | +316.6% |
Editas Medicine return by calendar year
| Year | EDIT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +30.2% | +11.7% | +18.6% |
| 2025 | +61.4% | +17.7% | +43.7% |
| 2024 | -87.5% | +24.9% | -112.3% |
| 2023 | +14.2% | +26.2% | -12.0% |
| 2022 | -66.6% | -18.2% | -48.4% |
| 2021 | -62.1% | +28.7% | -90.9% |
| 2020 | +136.8% | +18.4% | +118.4% |
| 2019 | +30.2% | +31.2% | -1.1% |
| 2018 | -26.0% | -4.6% | -21.4% |
| 2017 | +89.3% | +21.7% | +67.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: EDIT financials
No forecast, no recommendation. This page describes Editas Medicine Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.